Emerging Dermatological and Systemic Applications of Ustekinumab: Beyond Its Clinical Use in Psoriasis

Clinical, Cosmetic and Investigational Dermatology - New Zealand
doi 10.2147/ccid.s32149
Full Text
Abstract

Available in full text

Categories
Dermatology
Date
Authors

Unknown

Publisher

Informa UK Limited

Related search

Effectiveness of Resuming Ustekinumab Therapy in Psoriasis Patients With Metabolic Disorders. Clinical Experience

Vestnik dermatologii i venerologii
2019English

Comparative Assessment of Biologics in Treatment of Psoriasis: Drug Design and Clinical Effectiveness of Ustekinumab

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2011English

Systemic Sclerosis Pathogenesis and Emerging Therapies, Beyond the Fibroblast

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2019English

Risankizumab vs. Ustekinumab for Plaque Psoriasis

British Journal of Dermatology
DermatologyMedicine
2019English

Psoriasis: Therapie Mit Ustekinumab Ist Langzeitig Erfolgreich

hautnah dermatologie
2013English

Efficacy and Safety of Ustekinumab in Patients With Psoriasis and Psoriatic Arthritis

Clinical pharmacology and therapy
2018English

Exacerbation of Infliximab-Induced Paradoxical Psoriasis After Ustekinumab Therapy

Journal of Dermatology
DermatologyMedicine
2017English

Modulation of Inflammatory Gene Transcripts in Psoriasis Vulgaris: Differences Between Ustekinumab and Etanercept

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Risankizumab Versus Ustekinumab for Plaque Psoriasis: A Critical Appraisal

British Journal of Dermatology
DermatologyMedicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy